Clinical Trial Update: Safety and Efficacy of Venetoclax in Combination With Azacitidine and HA Regimen in the Treatment of AML in the Elderly [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating venetoclax with azacitidine and HA regimen for elderly patients with acute myeloid leukemia; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Venetoclax (venetoclax)

Snippet

Sponsor: ZePing Zhou | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: UNKNOWN